Bioline RX Ltd Sponsored ADR(DE:YP2)
€0.80-0.14 (-14.52%)
DE:YP2
Bioline RX Ltd Sponsored ADR earnings date
€0.80
At close:-0.14 (-14.52%)
Bioline RX Ltd Sponsored ADR (YP2) Q1 2026 Earnings Report
1 Followers
DE:YP2 Q1 2026 EPS Results
- Actual EPS
- EUR 0.00
- Consensus EPS
- -EUR 0.95
- Beat/Miss
- Beat by +EUR 0.95
- One Year Ago EPS
- EUR 0.00
DE:YP2 Q1 2026 Revenue Results
- Actual Revenue
- EUR 432.68K
- Expected Revenue
- EUR 311.98K
- Beat/Miss
- Beat by +EUR 120.70K
- YoY Revenue Growth
- +82.96%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/27/2026
- Time
- Before Open
- Conference Call
- Wednesday, May 27, 2026
DE:YP2 Upcoming Earnings
Bioline RX Ltd Sponsored ADR's next earnings date is estimated for March 30, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
DE:YP2 Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:YP2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 30, 2027 | 2026 (Q4) | ―- | -0.25 | ― | ― |
| Nov 18, 2026 | 2026 (Q3) | -0.35- | 0 | ― | |
| Aug 31, 2026 | 2026 (Q2) | 0.000.00 | 0 | ― | |
| May 27, 2026 | 2026 (Q1) | -0.950.00 | 0 | ― | |
| Mar 23, 2026 | 2025 (Q4) | -0.35-0.25 | -1.46 | 83.13% (+1.21) | |
| Nov 24, 2025 | 2025 (Q3) | -0.610.00 | 0 | ― | |
| Aug 14, 2025 | 2025 (Q2) | -0.320.00 | 0 | ― | |
| May 27, 2025 | 2025 (Q1) | ―0.00 | 0 | ― | |
| Mar 31, 2025 | 2024 (Q4) | -0.860.00 | 0 | ― | |
| Nov 25, 2024 | 2024 (Q3) | ―0.00 | -10.91 | 100.00% (+10.91) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

